Sustainability
What’s New
-
Chugai Continues to be Listed for All ESG Indices Adopted by GPIF (the Government Pension Investment Fund) of Japan
-
Chugai has been selected as a “Nadeshiko Brand” by the Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange as a listed company with outstanding capabilities to promote women’s participation in the workplace.
-
Chugai has been selected as a “Health & Productivity Stock 2025” by the Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange as an outstanding listed company engaging in a health and productivity management
-
Awarded "Human Capital Leaders 2024" and "Human Capital Management Quality 2024 (Gold)" in the "Human Capital Survey 2024"
Our Approach to Sustainability
Putting sustainability at the heart of our business
Creating shared value and developing together with society
We aim to lead solving social issues through our business activities, share the value created through these activities with our diverse stakeholders, and to grow together with society. Our basic management policy, based on this idea, is to “Create Shared Value” with society.
Through the innovation that only we can produce, we aim to “achieve advanced, sustainable patient-centric healthcare”
Concept image of Chugai’s basic management policy
To achieve sustainable healthcare
Creating innovative drugs and services
awaited
by patients around the world
Important issues to be resolved
(Materialities)
In order to “achieve advanced, sustainable patient-centric healthcare” while sharing value with stakeholders, we have defined 16 key issues as materialities and are working on them from a mid- to long-term perspective.
The 16 material issues are organized along three axes - Challenge, Co-creation, and Commitments - to create a story that is easily shared with internal and external stakeholders. This framework allows us to communicate our approach to materiality more clearly and effectively promote the creation of shared value.
Important issues to be resolved (Materialities)
In advancing our basic management policy of creating shared value, we have identified 16 important issues on which we should focus as materiality. These material issues will be reviewed regularly in response to changes in the environment and the progress of Chugai’s business activities. Sustainability is part of our management strategy, and we believe it is important to approach diverse initiatives in an integrated and strategic manner and to promote these activities.
- Creation of innovative drugs and services, powered by unique strength in science and technology
- Provision of individualized and optimal solutions to patients
- Access to healthcare
- Quality assurance and stable supply of products and services
- Safety of patients and clinical trial participants
- Co-creation of a healthcare ecosystem with society and community
- Human capital development
- Diversity, equity, and inclusion
- Employee well-being
- Privacy protection and responsible use of digital technology
- Respect for human rights
- Corporate governance and stakeholder engagement
- Ethics, compliance and risk management
- Climate change and energy countermeasures
- Contribution to circularity and water management
- Protection of biodiversity
The 16 material issues are organized along three axes - Challenge, Co-creation, and Commitments - to create a story that is easily shared with internal and external stakeholders. This framework allows us to communicate our approach to materiality more clearly and effectively promote the creation of shared value.
Pursuing Sustainability
Realizing sustainable healthcare and addressing societal sustainability from an ESG perspective
Providing value
Improving value for patients through products and services
Chugai's top priority is “patient-centric”, and we aim to contribute to the health and happiness of every patient. We will practice a patient-centric approach across the entire value chain, from research and development to drug safety, and contribute to the advancement of healthcare through the creation of innovative pharmaceuticals while also pursuing growth as a company.
-
Environment
Impact
- *1 Performance in 2024
- *2 Scope 1: Direct emissions from energy, Scope 2: Indirect emissions from energy
- *3 Results in 2024 compared to 2019
- *4 INTAGE Healthcare “Rep-i August 2024 Survey” (reprint prohibited); based on survey results for an overall company assessment targeting only physicians according to Chugai’s definition
- *5 INTAGE Healthcare Inc., 2024 questionnaire about safety information needs
- *6 Job-fill rate for science specialists/digital specialists/medical doctors actual results in 2024. Calculation based on the number of new hires
- *7 Managers with subordinates, based on Chugai Pharmaceutical Group enrollment in Japan, as of April 1, 2025
- *8 Based on non-consolidated financial reports, as of April 1, 2025
- *9 Actual results in 2024
- *10 Incorporated administrative agency for management and operation of pension reserve
- *11 Six indices: FTSE Blossom Japan Index, MSCI Japan Stock ESG Select Leaders Index, MSCI Japan Stock Empowering Women Index (WIN), Morningstar Japan ex-REIT Gender Diversity Tile Index, and S & P/JPX Carbon Effectiveness Index
- *1 Performance in 2024
- *2 Scope 1: Direct emissions from energy, Scope 2: Indirect emissions from energy
- *3 Results in 2024 compared to 2019
- *4 INTAGE Healthcare “Rep-i August 2024 Survey” (reprint prohibited); based on survey results for an overall company assessment targeting only physicians according to Chugai’s definition
- *5 INTAGE Healthcare Inc., 2024 questionnaire about safety information needs
- *6 Job-fill rate for science specialists/digital specialists/medical doctors actual results in 2024. Calculation based on the number of new hires
- *7 Managers with subordinates, based on Chugai Pharmaceutical Group enrollment in Japan, as of April 1, 2025
- *8 Based on non-consolidated financial reports, as of April 1, 2025
- *9 Actual results in 2024
- *10 Incorporated administrative agency for management and operation of pension reserve
- *11 Six indices: FTSE Blossom Japan Index, MSCI Japan Stock ESG Select Leaders Index, MSCI Japan Stock Empowering Women Index (WIN), Morningstar Japan ex-REIT Gender Diversity Tile Index, and S & P/JPX Carbon Effectiveness Index
People and Activities
Toward the creation of continuous innovation.
The Story of Our
Challenges
Contents List
- Environmental, Health and Safety Policy/Basic Approach
- EHS Promotional Activities System
- Mid-Term Environmental Goals 2030
- Disclosures based on the TCFD recommendations
- Climate Change Countermeasures
- Recycling-oriented resource usage
- Protection of Biodiversity
- Education and Training
- Environmental Investment
- Environmental, Health and Safety Policy/Basic Approach
- EHS Promotional Activities System
- Goals and Initiatives
- Chugai Group Declaration on Health
- Health and Productivity Management Map
- Countermeasures against Smoking
- Health and Safety Activities
- Preventing occupational injuries
- Education and Training